Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
暂无分享,去创建一个
Rui Henrique | Carmen Jerónimo | David Sidransky | Jorge Oliveira | D. Sidransky | C. Lopes | Jorge Oliveira | R. Henrique | C. Jerónimo | H. Usadel | Cristina Silva | Henning Usadel | Cristina Silva | Carlos Lopes
[1] D. Sidransky,et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. , 2001, Journal of the National Cancer Institute.
[2] J. Herman,et al. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. , 1998, Cancer research.
[3] S. Baylin,et al. Aging and DNA methylation in colorectal mucosa and cancer. , 1998, Cancer research.
[4] J. Herman,et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.
[5] J. Herman,et al. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] A. Olek,et al. A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.
[7] W. Isaacs,et al. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] K. Livak,et al. Real time quantitative PCR. , 1996, Genome research.
[9] R. Sharifi,et al. Evaluation of cytologic techniques for diagnosis of prostate cancer. , 1983, Urology.
[10] P. Laird,et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.
[11] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Scher,et al. Principles and Practice of Genitourinary Oncology , 1997 .
[13] E. Crawford,et al. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. , 2000, Molecular and cellular probes.
[14] M. Toyota,et al. CpG island methylator phenotypes in aging and cancer. , 1999, Seminars in cancer biology.
[15] Y. Lo,et al. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. , 1999, Cancer research.
[16] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[17] J. Brooks,et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[18] J. Herman,et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. , 1997, Cancer research.
[19] S. Leung,et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. , 1999, Cancer research.
[20] J. Brooks,et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] K. Miller,et al. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. , 2000, Cancer research.
[22] J. Herman,et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. , 1999, Journal of the National Cancer Institute.
[23] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.